{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:57:34Z","timestamp":1759229854089},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,22]]},"DOI":"10.7759\/cureus.65097","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T12:35:58Z","timestamp":1721651758000},"source":"Crossref","is-referenced-by-count":1,"title":["Successful Treatment of Relapsing Chronic Eosinophilic Pneumonia With Mepolizumab: A Case Report"],"prefix":"10.7759","author":[{"given":"Lauren","family":"Worth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Khreisat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Iacobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2013.34.3628","article-title":"Primary eosinophilic lung diseases","volume":"34","author":"Rose DM","year":"2013","unstructured":"Rose DM, Hrncir DE. Primary eosinophilic lung diseases. Allergy Asthma Proc. 2013, 34:19-25. 10.2500\/aap.2013.34.3628","journal-title":"Allergy Asthma Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198805000-00002","article-title":"Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature","volume":"67","author":"Jederlinic PJ","year":"1988","unstructured":"Jederlinic PJ, Sicilian L, Gaensler EA. Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore). 1988, 67:154-62. 10.1097\/00005792-198805000-00002","journal-title":"Medicine (Baltimore)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2013.74.2.51","article-title":"Acute eosinophilic pneumonia","volume":"74","author":"Sohn JW","year":"2013","unstructured":"Sohn JW. Acute eosinophilic pneumonia. Tuberc Respir Dis (Seoul). 2013, 74:51-5. 10.4046\/trd.2013.74.2.51","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199809000-00001","article-title":"Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies \"Orphelines\" Pulmonaires (GERM\"O\"P)","volume":"77","author":"Marchand E","year":"1998","unstructured":"Marchand E, Reynaud-Gaubert M, Lauque D, Durieu J, Tonnel AB, Cordier JF. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies \"Orphelines\" Pulmonaires (GERM\"O\"P). Medicine (Baltimore). 1998, 77:299-312. 10.1097\/00005792-199809000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/11584340-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody","volume":"50","author":"Smith DA","year":"2011","unstructured":"Smith DA, Minthorn EA, Beerahee M. Pharmacokinetics and pharmacodynamics of mepolizumab, an anti-interleukin-5 monoclonal antibody. Clin Pharmacokinet. 2011, 50:215-27. 10.2165\/11584340-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-020-00336-3","article-title":"Real-life study of mepolizumab in idiopathic chronic eosinophilic pneumonia","volume":"198","author":"Brenard E","year":"2020","unstructured":"Brenard E, Pilette C, Dahlqvist C, Colinet B, Schleich F, Roufosse F, Froidure A. Real-life study of mepolizumab in idiopathic chronic eosinophilic pneumonia. Lung. 2020, 198:355-60. 10.1007\/s00408-020-00336-3","journal-title":"Lung"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2016.04.015","article-title":"Eosinophilic lung diseases","volume":"37","author":"Cottin V","year":"2016","unstructured":"Cottin V. Eosinophilic lung diseases. Clin Chest Med. 2016, 37:535-56. 10.1016\/j.ccm.2016.04.015","journal-title":"Clin Chest Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00812.x","article-title":"Eosinophilic pneumonias","volume":"60","author":"Cottin V","year":"2005","unstructured":"Cottin V, Cordier JF. Eosinophilic pneumonias. Allergy. 2005, 60:841-57. 10.1111\/j.1398-9995.2005.00812.x","journal-title":"Allergy"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1325164","article-title":"Update on eosinophilic lung diseases","volume":"33","author":"Bhatt NY","year":"2012","unstructured":"Bhatt NY, Allen JN. Update on eosinophilic lung diseases. Semin Respir Crit Care Med. 2012, 33:555-71. 10.1055\/s-0032-1325164","journal-title":"Semin Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00093","article-title":"The biology of eosinophils and their role in asthma","volume":"4","author":"McBrien CN","year":"2017","unstructured":"McBrien CN, Menzies-Gow A. The biology of eosinophils and their role in asthma. Front Med (Lausanne). 2017, 4:93. 10.3389\/fmed.2017.00093","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1998.275.3.C623","article-title":"The mechanism of IL-5 signal transduction","volume":"275","author":"Adachi T","year":"1998","unstructured":"Adachi T, Alam R. The mechanism of IL-5 signal transduction. Am J Physiol. 1998, 275:C623-33. 10.1152\/ajpcell.1998.275.3.C623","journal-title":"Am J Physiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.8.2106110","article-title":"Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia","volume":"165","author":"Miyazaki E","year":"2002","unstructured":"Miyazaki E, Nureki S, Fukami T, et al.. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am J Respir Crit Care Med. 2002, 165:1125-31. 10.1164\/ajrccm.165.8.2106110","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2018.1502301","article-title":"Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data","volume":"56","author":"Ortega H","year":"2019","unstructured":"Ortega H, Llanos JP, Lafeuille MH, et al.. Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data. J Asthma. 2019, 56:808-15. 10.1080\/02770903.2018.1502301","journal-title":"J Asthma"},{"key":"ref14","unstructured":"Highlights of prescribing information (mepolizumab). (2019). https.\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/125526s012,761122s002s003lbl.pdf."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.130939.2","article-title":"Case report: mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia","volume":"12","author":"Daboussi S","year":"2023","unstructured":"Daboussi S, Essebaa S, Mhamdi S, Aichaouia C, Hela G, Ayadi A, Zied M. Case report: mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia. F1000Res. 2023, 12:337. 10.12688\/f1000research.130939.2","journal-title":"F1000Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2018.1534966","article-title":"Favorable response to asthma-dosed subcutaneous mepolizumab in eosinophilic pneumonia","volume":"56","author":"Lin RY","year":"2019","unstructured":"Lin RY, Santiago TP, Patel NM. Favorable response to asthma-dosed subcutaneous mepolizumab in eosinophilic pneumonia. J Asthma. 2019, 56:1193-7. 10.1080\/02770903.2018.1534966","journal-title":"J Asthma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-5-3","article-title":"Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance","volume":"9","author":"Kisling A","year":"2020","unstructured":"Kisling A, Jones J, Hixson C, Hostler D, Hostler J. Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance. Drugs Context. 2020, 9:10.7573\/dic.2020-5-3","journal-title":"Drugs Context"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2018.1543434","article-title":"Anti-interleukin (IL)-5 as a steroid-sparing agent in chronic eosinophilic pneumonia","volume":"57","author":"Sarkis E","year":"2020","unstructured":"Sarkis E, Patel S, Burns K, Batarseh H, Mador MJ. Anti-interleukin (IL)-5 as a steroid-sparing agent in chronic eosinophilic pneumonia. J Asthma. 2020, 57:82-6. 10.1080\/02770903.2018.1543434","journal-title":"J Asthma"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2023.2239343","article-title":"Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing","volume":"61","author":"Prieto-Garc\u00eda A","year":"2024","unstructured":"Prieto-Garc\u00eda A, Peligros MI, P\u00e9rez Tamayo I, Zubeldia JM, \u00c1lvarez-Sala L, Lavilla C. Long-term use of mepolizumab in a case of chronic eosinophilic pneumonia: extending interval dosing. J Asthma. 2024, 61:69-71. 10.1080\/02770903.2023.2239343","journal-title":"J Asthma"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/274900-successful-treatment-of-relapsing-chronic-eosinophilic-pneumonia-with-mepolizumab-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T12:36:03Z","timestamp":1721651763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/274900-successful-treatment-of-relapsing-chronic-eosinophilic-pneumonia-with-mepolizumab-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.65097","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,22]]}}}